Penumbra, Inc. (PEN)
NYSE: PEN · Real-Time Price · USD
242.54
-0.98 (-0.40%)
Dec 20, 2024, 4:00 PM EST - Market closed
Penumbra Employees
Penumbra had 4,200 employees as of December 31, 2023. The number of employees increased by 300 or 7.69% compared to the previous year.
Employees
4,200
Change (1Y)
300
Growth (1Y)
7.69%
Revenue / Employee
$277,090
Profits / Employee
$8,225
Market Cap
9.31B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 4,200 | 300 | 7.69% |
Dec 31, 2022 | 3,900 | 100 | 2.63% |
Dec 31, 2021 | 3,800 | 500 | 15.15% |
Dec 31, 2020 | 3,300 | 600 | 22.22% |
Dec 31, 2019 | 2,700 | 500 | 22.73% |
Dec 31, 2018 | 2,200 | 500 | 29.41% |
Dec 31, 2017 | 1,700 | 200 | 13.33% |
Dec 31, 2016 | 1,500 | 400 | 36.36% |
Dec 31, 2015 | 1,100 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Encompass Health | 37,761 |
Charles River Laboratories International | 21,800 |
Bio-Rad Laboratories | 8,030 |
Bio-Rad Laboratories | 8,030 |
Exact Sciences | 6,600 |
Qiagen | 5,967 |
Masimo | 3,800 |
Exelixis | 1,310 |
PEN News
- 4 days ago - Penumbra Is Poised For Growth As Blood Clot Awareness Rises: Analyst - Benzinga
- 4 weeks ago - Penumbra, Inc. to Present at the Piper Sandler 36th Annual Healthcare Conference - PRNewsWire
- 6 weeks ago - New Late Breaking Data Show Patients Treated with Penumbra's Computer Assisted Vacuum Thrombectomy Technology for Pulmonary Embolism Experience Shorter Hospital Stays and Fewer Complications Compared to Other Treatment Options - PRNewsWire
- 7 weeks ago - Penumbra, Inc. (PEN) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - Penumbra, Inc. Reports Third Quarter 2024 Financial Results - PRNewsWire
- 2 months ago - Penumbra, Inc. Announces Completion of THUNDER IDE Study Enrollment for Acute Ischemic Stroke - PRNewsWire
- 2 months ago - Penumbra, Inc. Schedules Third Quarter 2024 Earnings Release and Conference Call for October 30, 2024 - PRNewsWire
- 3 months ago - Penumbra Receives CE Mark for Computer Assisted Vacuum Thrombectomy Technologies - Lightning Flash™ 2.0 and Lightning Bolt™ 7 - in Europe - PRNewsWire